385 related articles for article (PubMed ID: 31332661)
1. Pseudoginsenoside-F11 Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Neutrophil Infiltration and Accelerating Neutrophil Clearance.
Wang P; Hou Y; Zhang W; Zhang H; Che X; Gao Y; Liu Y; Yang D; Wang J; Xiang R; Zhao M; Yang J
Inflammation; 2019 Oct; 42(5):1857-1868. PubMed ID: 31332661
[TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway.
Yaxin W; Shanglong Y; Huaqing S; Hong L; Shiying Y; Xiangdong C; Ruidong L; Xiaoying W; Lina G; Yan W
J Surg Res; 2014 May; 188(1):213-21. PubMed ID: 24387839
[TBL] [Abstract][Full Text] [Related]
4. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
[TBL] [Abstract][Full Text] [Related]
5. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages.
Bao S; Zou Y; Wang B; Li Y; Zhu J; Luo Y; Li J
Int Immunopharmacol; 2015 Sep; 28(1):429-34. PubMed ID: 26122136
[TBL] [Abstract][Full Text] [Related]
7. MARESIN 1 PREVENTS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL SURVIVAL AND ACCELERATES RESOLUTION OF ACUTE LUNG INJURY.
Gong J; Liu H; Wu J; Qi H; Wu ZY; Shu HQ; Li HB; Chen L; Wang YX; Li B; Tang M; Ji YD; Yuan SY; Yao SL; Shang Y
Shock; 2015 Oct; 44(4):371-80. PubMed ID: 26196844
[TBL] [Abstract][Full Text] [Related]
8. Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury.
Tan W; Chen L; Wang YX; Hu LS; Xiong W; Shang Y; Yao SL
Chin Med J (Engl); 2018 May; 131(10):1167-1173. PubMed ID: 29553051
[TBL] [Abstract][Full Text] [Related]
9. Fibrocytes Ameliorate Acute Lung Injury by Decreasing Inflammatory Cytokine and Chemokine Levels and Reducing Neutrophil Accumulation in the Lung.
Tai W; Xu Y; Ding J; Wu H; Du M; Qu X; Gao L; Li J; Dong Z
Cell Physiol Biochem; 2017; 44(4):1526-1536. PubMed ID: 29197869
[TBL] [Abstract][Full Text] [Related]
10. B7H3 ameliorates LPS-induced acute lung injury via attenuation of neutrophil migration and infiltration.
Li Y; Huang J; Foley NM; Xu Y; Li YP; Pan J; Redmond HP; Wang JH; Wang J
Sci Rep; 2016 Aug; 6():31284. PubMed ID: 27515382
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
12. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
13. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity.
Wessels I; Pupke JT; von Trotha KT; Gombert A; Himmelsbach A; Fischer HJ; Jacobs MJ; Rink L; Grommes J
Thorax; 2020 Mar; 75(3):253-261. PubMed ID: 31915307
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of
Fu S; Lu W; Yu W; Hu J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31186277
[No Abstract] [Full Text] [Related]
16. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
[TBL] [Abstract][Full Text] [Related]
17. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice.
Liu L; Xiong H; Ping J; Ju Y; Zhang X
J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
Tang Y; Chen Y; Chu Z; Yan B; Xu L
Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
[TBL] [Abstract][Full Text] [Related]
19. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
20. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
